Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 78792034 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Lisa A. Dunner |
Attorney Name | Lisa A. Dunner |
Attorney Docket Number | FLAM-018 |
Law Office Assigned | M60 |
Employee Name | COWARD, KATHRYN E |
2006-01-15 | Application Filed |
2006-11-20 | Abandon |
2006-12-22 | Location: TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED |
2006-12-22 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Address | 33, Avenue du Dr. Georges Levy 69693 Venissieux C FR |
Legal Entity Type | Corporation |
Legal Entity State | FR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | capsules for the oral administration of one or more medicinal and/or nutritional active principles (AP) and each providing a sustained and a controlled release of the AP in the small intestine, where the active principle can be antiulcer, antidiabetic, anticoagulant, antithrombic, hypolipaemic, antiarrhythmic, vasodilatory, antianginal, antihypertensive, and vasoprotective agents, fertility enhancers, labor inducers and inhibitors, and contraceptive, antibiotic, antifungal, antiviral, anticancer, anti-inflammatory, analgesic, antiepileptic, antiparkinsonian, neuroleptic, hypnotic, anxiolytic, psychostimulatory, antimigraine, antidepressant, antitussive, antihistamine or anti-allergic agents, such as but not limited to acetylsalicylic acid, pentoxifyllin, prazosin, acyclovir, nifedipin, diltiazem, naproxen, ibuprofen, flurbiprofen, ketoprofen, fenoprofen, indomethacin, diclofenac, fenitazac, oestradiol valerate, metoprolol, sulpiride, captopril, cimetidin, zidovudin, nicardipin, terfanadin, atenolol, salbutamol, carbamazepin, ranitidin, enalapril, simvastatin, fluoxetin, alprazolam, famotidin, ganciclovir, famiciclovir, spironolacton, 5-ASA, quinidin, perindopril, morphin, pentazocin, paracetamol, omeprazol, metoclopramid and mixtures thereof, and where the active principle can also be medicinal-nutritional and/or dietary supplements of mixtures thereof, such as but not limited to vitamins, amino acids, antioxidants, trace elements or mixtures thereof; Medicinal and pharmaceutical preparations in the form of capsules having controlled release active principles |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2006-01-19 | 1 NWAP I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2006-05-18 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2006-05-19 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2006-05-19 | 4 GNRT F:First Action |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2006-12-22 | 5 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2006-12-26 | 6 MAB2 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.